HUL To Fund Comprehensive Research In India To Identify Factors Driving COVID-19 Vax Efficacy

Sep 09,2021

This research is being enabled by the Office of the Principal Scientific Advisor to the Government of India’s programme to stimulate collaborations between industry and academia. It is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes in Bangalore (National Centre for Biological Science (NCBS-TIFR), a Centre of Tata Institute for Fundamental Research; Institute for Stem Cell Science and Regenerative Medicine, a DBT Institute) and Pune (Indian Institute for Science Education and Research, Pune (IISER-Pune), CSIR-National Chemical Laboratory), and Clinical Research Centres in Bangalore (Baptist Hospital and St John’s Research Institute), Vellore (Christian Medical College), and Pune (KEM Hospital and Research Centre and Symbiosis Hospital and Research Centre). HUL will also provide additional analytical and data analyses support through its R&D scientists to the consortium partners, as needed.

CLICK HERE to the read the news

events